Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jérôme Weinbach"'
Autor:
Serge Amselem, Sonia Gueguen, Jérôme Weinbach, Annick Clement, Paul Landais, for the RaDiCo Program
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-12 (2021)
Abstract Background Rare diseases (RDs) affect nearly 3 million people in France and at least 26–30 million people in Europe. These diseases, which represent a major medical concern, are mainly of genetic origin, often chronic, progressive, degener
Externí odkaz:
https://doaj.org/article/671678cf31a946c283d222d96b81ad55
Autor:
Marie-Marie Olive, Jean-Luc Angot, Aurélie Binot, Alice Desclaux, Loïc Dombreval, Thierry Lefrançois, Antoine Lury, Mathilde Paul, Marisa Peyre, Frédéric Simard, Jérôme Weinbach, François Roger
Publikováno v:
Natures Sciences Sociétés
Natures Sciences Sociétés, 2022, 30 (1), pp.72-81. ⟨10.1051/nss/2022023⟩
Natures Sciences Sociétés, 2022, 30 (1), pp.72-81. ⟨10.1051/nss/2022023⟩
En mars 2021, Montpellier Université d’excellence (MUSE) et Agropolis International ont réuni des décideurs, acteurs opérationnels, représentants d’organisations internationales et scientifiques pour partager leurs expériences des approches
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47a1449379aa038fa8aac8ffe0b1f2bf
https://hal.science/hal-03799641
https://hal.science/hal-03799641
Background: Rare diseases (RDs) affect nearly 3 million people in France and at least 26-30 million people in Europe. These diseases, which represent a major medical concern, are mainly of genetic origin, often chronic, progressive, degenerative, lif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9aad84f3a84f5748e61bbd119f4e053b
https://doi.org/10.21203/rs.3.rs-610226/v1
https://doi.org/10.21203/rs.3.rs-610226/v1
Autor:
Paul Landais, Heimo Müller, Deborah Mascalzoni, Virginie Bros-Facer, Yllka Kodra, Ronald Cornet, Daniel Renault, Paola Torreri, Claudio Carta, Marco Roos, Marieke Van Meel, Alessio Coi, Annika Jacobsen, Veronica Popa, Manuel Posada-de-la-Paz, Yaffa R. Rubinstein, Rainald von Gizycki, S Faisal Ahmed, Michele Santoro, Estrella Lopez, Robert Reis, Jérôme Weinbach, David van Enckevort, Domenica Taruscio, S Lydie Lemonnier, Anna Ambrosini, Sabina Gainotti, Hanns Lochmüller, Fabrizio Bianchi
Publikováno v:
International Journal of Environmental Research and Public Health, 15(8)
International Journal of Environmental Research and Public Health
Repisalud
Instituto de Salud Carlos III (ISCIII)
International Journal of Environmental Research and Public Health, Vol 15, Iss 8, p 1644 (2018)
International Journal of Environmental Research and Public Health
Repisalud
Instituto de Salud Carlos III (ISCIII)
International Journal of Environmental Research and Public Health, Vol 15, Iss 8, p 1644 (2018)
Rare diseases (RD) patient registries are powerful instruments that help develop clinical research, facilitate the planning of appropriate clinical trials, improve patient care, and support healthcare management. They constitute a key information sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ade81687afb2be56949118ac12a5edc
http://hdl.handle.net/1887/86526
http://hdl.handle.net/1887/86526
Autor:
Yllka, Kodra, Manuel, Posada de la Paz, Alessio, Coi, Michele, Santoro, Fabrizio, Bianchi, Faisal, Ahmed, Yaffa R, Rubinstein, Jérôme, Weinbach, Domenica, Taruscio
Publikováno v:
Advances in experimental medicine and biology. 1031
In the field of rare diseases, registries are considered power tool to develop clinical research, to facilitate the planning of appropriate clinical trials, to improve patient care and healthcare planning. Therefore high quality data of rare diseases
Autor:
Jérôme Weinbach, Alessio Coi, Yaffa R. Rubinstein, Manuel Posada de la Paz, Michele Santoro, Fabrizio Bianchi, Faisal Ahmed, Yllka Kodra, Domenica Taruscio
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9783319671420
In the field of rare diseases, registries are considered power tool to develop clinical research, to facilitate the planning of appropriate clinical trials, to improve patient care and healthcare planning. Therefore high quality data of rare diseases
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::922ec55aff8b81990c68fc696edc74e1
https://doi.org/10.1007/978-3-319-67144-4_8
https://doi.org/10.1007/978-3-319-67144-4_8
Autor:
Gulay Korukluoglu, Jérôme Weinbach, Manfred Weidmann, Friedemann Weber, Ali Mirazimi, Anna Papa-Konidari, Peter Leyssen
Publikováno v:
Antiviral Research. 90:A59